Comparative inhibitory effects of magnolol, honokiol, eugenol and bis-eugenol on cyclooxygenase-2 expression and nuclear factor-kappa B activation in RAW264.7 macrophage-like cells stimulated with fimbriae of Porphyromonas gingivalis

In Vivo

Volumn 26, Issue 6, 2012, Pages 941-950

  Murakami, Yukio ^a   Kawata, Akifumi ^a   Seki, Yuya ^a   Koh, Teho ^a   Yuhara, Kenji ^a   Maruyama, Takehisa ^a   Machino, Mamoru ^a   Ito, Shigeru ^b   Kadoma, Yoshinori ^b   Fujisawa, Seiichiro ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Antioxidative activity; COX 2; Cytotoxicity; Eugenol; Honokiol; Magnolol; NF B; Orbital energy; RAW264.7 cells

Indexed keywords

AZOBISISOBUTYRONITRILE; BISEUGENOL; BUTYRONITRILE; CYCLOOXYGENASE 2; EUGENOL; HONOKIOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAGNOLOL; MESSENGER RNA; METHACRYLIC ACID METHYL ESTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; DENSITY FUNCTIONAL THEORY; DRUG CYTOTOXICITY; ENERGY; ENTHALPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIMBRIA; MACROPHAGE; MOUSE; NONHUMAN; ORBITAL ENERGY; PHENOLIC BOND DISSOCIATION ENTHALPY; POLYMERIZATION; PORPHYROMONAS GINGIVALIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84872200083     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LBA and Lipsky PE: Cyclooxygenase in biology and disease. FASEB J 12: 1063-1073, 1998.
2. Xie W, Merrill JR. Bradsha WS and Simmons DL: Structural determination and promoter analysis of the chicken mitogen-inducible prostaglandin G/H synthase gene and genetic mapping of the murine homolog. Arch Biochem Biophys 300: 247-252, 1993.
3. D'Acquisto F, Iuvone T, Rombola L, Sautebin L, Di Rosa M and Carnuccio R: Involvement of NF-kappa B in the regulation of cyclooxygenase-2 protein in LPS-stimulated J774 macrophages. FEBS Lett 418: 175-178, 1997.
4. Kang Y-J, Wingerd BA, Arakawa T and Smith WL: Cyclooxygenase-2 gene transcription in a macrophage model of inflammation. J Immunol 177: 8111-8122, 2006.
5. Wang JP, Hsu MF, Raung SL, Chen CC, Kuo JS and Teng CM: Anti-inflammatory and analgesic effects of magnolol. Naunyn Schmiedebergs Arch Pharmacol 346: 707-712, 1992.
6. Kadoma Y, Murakami Y, Atsumi T, Ito S and Fujisawa S: Chapter 5 Cloves (Eugenol). In: Molecular Targets and Therapeutic Uses of Spices. Modern Uses for Ancient Medicine. Aggarwal BB and Kunnumakkara AB (eds.). World Scientific Publishing Co. Pre. Ltd, Singapore, pp. 117-148, 2009.
7. Zhao C and Liu ZQ: Comparison of antioxidant abilities of magnolol and honokiol to scavenge radicals and to protect DNA. Biochimie 93: 1755-1760, 2011.
8. Lin YR, Chen HH, Ko CH and Chen MH: Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur J Pharmacol 537: 64-69, 2006.
9. Shen JL, Man KM, Huang PH, Chen WC, Chen DC, Cheng YW, Liu PL, Chou MC and Chen YH: Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders. Molecules 15: 6452-6465, 2010.
10. Lee J, Jung E, Park J, Jung K, Lee S, Hong S, Park E, Kim J, Park S and Park D: Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling. Planta Med 71: 338-343, 2005.
11. Murakami Y, Yuhara K, Takada N, Arai T, Tsuda S, Takamatsu S, Machino M and Fujisawa S: Effect of melatonin on cyclooxygenase-2 expression and nuclear factor kappa B activation in RAW264.7 macrophage-like cells stimulated with fimbriae of Porphyromonas gingivalis. In Vivo 25: 641-648, 2011.
12. Murakami Y, Shoji M, Ogiwara T, Tanaka S, Yokoe I and Fujisawa S: Preventive effect of ortho dimer of butylated hydroxyanisole on activator protein-1 activation and cyclooxygenase-2 expression in macrophages stimulated by fimbriae of Porphyromonas gingivalis, an oral anaerobe. Anticancer Res 26: 2915-2920, 2006.
13. Iwai T, Inoue Y, Umeda M, Huang Y. Kurihara N, Koike M and Ishikawa I: Oral bacteria in the occluded arteries of patients with Buerger disease. J Vasc Surg 42: 107-115, 2005.
14. Miyazaki Y, Okamoto E, González-Alva P, Hayashi J, Ishige T, Kikuchi K, Nemoto N, Shin K, Sakashita H, Ochiai K and Kusama K: The significance of podoplanin expression in human inflamed gingiva. J Oral Sci 51: 283-287, 2009.
15. Chen XR, Lu R, Dan HX, Liao G, Zhou M, Li XY and Ji N: Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells. Int J Oral Sci 3: 34-42, 2011.
16. Satoh K, Sakagami H, Yokoe I, Kochi M, and Fujisawa S: Interaction between eugenol-related compounds and radicals. Anticancer Res 18: 425-428, 1998.
17. Kadoma Y and Fujisawa S: Comparative radical-scavenging activity of curcumin and tetrahydrocurcumin with thiols as measured by the induction period method. In Vivo 21: 979-982, 2007.
18. Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y and Ueno K: A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta 44: 1299-1305, 1997.
19. Yoshimura F, Takahashi K, Nodasaka Y and Suzuki T: Purification and characterization of a novel type of fimbriae from the oral anaerobe Bacteroides gingivalis. J Bacteriol 160: 949-954, 1984.
20. Hanazawa S, Murakami Y, Hirose K, Amano S, Ohmori Y, Higuchi H and Kitano S: Bacteroides (Porphyromonas) gingivalis fimbriae activating mouse peritoneal macrophages and gene expression and production of interleukin-1. Infect Immun 59: 1972-1977, 1991.
21. Hanazawa S, Kawata Y, Murakami Y, Naganuma K, Amano S, Yuko M and Kitano S: Porphyromonas gingivalis fimbria-stimulated bone resorption in vitro is inhibited by a tyrosine kinase inhibitor. Infect Immun 63: 2374-2377, 1995.
22. Smith PM, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ and Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
23. Renard P, Ernest I, Houbion A, Art M, LeCalvez H, Raes M and Remacle J: Development of a sensitive multi-well colorimetric assay for NF-κB. Nucleic Acids Res 29: E21, 2001.
24. Koopmans T: The distribution of wave function and characteristic value among the individual electrons of an atom. Physica 1: 104-113, 1993.
25. Lai CS, Lai YS, Kuo DH, Wu CH, Ho CH and Pan MH: Magnolol potently suppressed lipopolysaccharide-induced iNOS and COX-2 expression via down-regulating MAPK and NF-κB signaling pathways. J Funct Foods 3: 198-206, 2011.
26. Chang B, Lee Y, Ku Y, Bae K and Chung C: Antimicrobial activity of magnolol and honokiol against periodontopathic microorganisms. Planta Med 64: 367-369, 1998.
27. Tse AK, Wan CK, Zhu GY, Shen XL, Cheung HY, Yang M and Fong WF: Magnolol suppresses NF-kappaB activation and NFkappaB regulated gene expression through inhibition of IkappaB kinase activation. Mol Immunol 44: 2647-2658, 2007.
28. Murakami Y, Shoji M, Hanazawa S, Tanaka S and Fujisawa S: Preventive effect of bis-eugenol, a eugenol ortho dimer, on lipopolysaccharide-stimulated nuclear factor kappa B activation and inflammatory cytokine expression in macrophages. Biochem Pharmacol 66: 1061-1066, 2003.
29. Murakami Y, Machino M and Fujisawa S: Porphyromonas gingivalis fimbria-induced expression of inflammatory cytokines and cyclooxygenase-2 in mouse macrophages and its inhibition by the bioactive compounds fibronectin and melatonin. ISRN Dent 2012: 350859, 2012.
30. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D and Miyamoto S: Rel/NF-kB/IkB family: Intimate tales of association and dissociation. Genes Dev 15: 2723-2735, 1995.
31. Sojar HT, Sharma A and Genco RJ: Porphyromonas gingivalis fimbriae bind to cytokeratin of epithelial cells. Infect Immun 70: 96-101, 2002.
32. Takeshita A, Murakami Y, Yamashita Y, Ishida M, Fujisawa S, Kitano S and Hanazawa S: Porphyromonas gingivalis fimbriae use beta2 integrin (CD11/CD18) on mouse peritoneal macrophages as a cellular receptor, and the CD18 beta chain plays a functional role in fimbrial signaling. Infect Immun 66: 4056-4060, 1998.
33. Murakami Y, Iwahashi H, Yasuda H, Umemoto T, Namikawa I, Kitano S and Hanazawa S: Porphyromonas gingivalis fimbrillin is one of the fibronectin-binding proteins. Infect Immun 64: 2571-2576, 1996.
34. Murakami Y, Hanazawa S, Watanabe A, Naganuma K, Iwasaka H, Kawakami K and Kitano S: Porphyromonas gingivalis fimbriae induce a 68-kiloDalton phosphorylated protein in macrophages. Infect Immun 62: 5242-5246, 1994.
35. Ogata M, Hoshi M, Shimotohno K, Urano S and Endo T: Antioxidant activity of magnolol, honokiol, and related phenolic compounds. J Am Oil Chem Soc 5: 557-562, 1997.
36. Fujisawa S, Atsumi T, Kadoma Y and Sakagami H: Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity. Toxicology 177: 39-54, 2002.
37. Dikalov S, Losik T and Arbiser JL: Honokiol is a potent scavenger of superoxide and peroxyl radicals. Biochem Pharmacol 76: 589-596, 2008.
38. Murakami Y, Ishii H, Hoshina S, Takada N, Ueki A, Tanaka S, Kadoma Y, Ito S, Machino M and Fujisawa S: Antioxidant and cyclooxygenase-2 inhibiting activity of 4,4′-biphenol, 2,2′-biphenol and phenol. Anticancer Res 29: 2403-2410, 2009.